<DOC>
	<DOCNO>NCT00347022</DOCNO>
	<brief_summary>This clinical study Xenetix 300 Multislice Computed Tomography ( MSCT ) pediatric indication .</brief_summary>
	<brief_title>A Clinical Study Xenetix 300 Multislice Computed Tomography ( CT ) Pediatric Indications</brief_title>
	<detailed_description />
	<criteria>Child age 1 year 16 year Patients normal renal function ( creatinine clearance &gt; 60 ml/min/1.73 m2 ) Patient require MSCT contrast medium injection diagnosis Patient blood sample plan 24 hour precede MSCT scan Female patient childbearing potential must effective contraception ( contraceptive pill intrauterine device ) , surgically sterilize blood beta human chorionic gonadotropin ( ÃŸHCG ) test prior product injection . Parent ( ) patient ( child sufficient intellectual maturity ) provide his/her/their write informed consent child participate trial . Patient national health insurance Patients receive diuretic biguanide treatment 48 hour precede MSCT scan . Patient know allergy iodinate contrast agent . Patient treat nephrotoxic drug within one week first blood sample Patients plan either undergo surgery receive chemotherapy within 72 hour post injection ( ie : blood test 72 hour post injection ) Patient receive planned receive iodinate contrast agent 48 hour precede MSCT scan . Breast feeding patient . Pregnant patient . Patient already include trial Patient include another clinical trial involve investigational drug . Patients whose degree cooperation incompatible carrying study</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Multislice compute tomography ( MSCT ) indication</keyword>
</DOC>